Syphillis microbiology

Reading File
Finding Sources
Finding Sources
Searching the Web

Treponema pallidum syphilis microbiology morphology pathogenesis

Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Loading Image
Reading File
Finding Sources
Reading File
Loading Image
Perfect! I have comprehensive material. Let me now compile a complete answer on syphilis microbiology with all the key details.

Syphilis Microbiology

Syphilis is a chronic sexually transmitted infection caused by Treponema pallidum subspecies pallidum, a spirochete bacterium. Here's a detailed overview of its microbiology:

Organism Structure and Morphology

Treponema pallidum is a delicate, gram-negative spirochete with the following characteristics:
  • Morphology: A corkscrew-shaped spirochete with 5-20 μm length, characterized by 4-14 regular spiral coils that resemble a gentleman bowing (Sherris & Ryan's Medical Microbiology)
  • Motility: Actively motile with three characteristic movements - axial projection, rotation on its long axis, and side-to-side bending/twisting - while maintaining precise spiral uniformity
  • Gram staining: Not visible on routine Gram stain; requires darkfield microscopy, immunofluorescence, or silver impregnation for visualization
  • Outer membrane structure: Unique gram-negative structure but crucially lacks lipopolysaccharide (LPS) and contains extremely few surface proteins - only about 1% the protein content of E. coli (Andrews' Diseases of the Skin)

Metabolic Limitations

T. pallidum is a "minimalist pathogen" with severe growth constraints:
  • Genome: Contains only about one-quarter the number of genes of most bacteria
  • Metabolic deficiency: Lacks catalase, oxidase, and efficient ATP-producing pathways (tricarboxylic acid cycle and electron transport chain)
  • Growth rate: Extremely slow with a mean generation time exceeding 30 hours
  • Culture: Cannot be cultured in vitro; sustained growth only achieved in animal models (rabbit tests), which serve as the sole source of bacteria for diagnostic reagents
  • Environmental sensitivity: Dies rapidly on drying and is readily killed by detergents and disinfectants

Pathogenesis

Syphilis overview showing progression from primary chancre through secondary systemic infection to tertiary cardiovascular and neurologic complications with Treponema pallidum depicted
Timeline of progression (illustrated above):
  1. Inoculation: 10-90 days incubation (average 3 weeks)
  2. Primary syphilis: Painless ulcer (chancre) with regional lymphadenopathy
  3. Hematogenous dissemination: Organisms reach bloodstream within hours and multiple organs (including brain) within 18 hours of infection
  4. Secondary syphilis: 3-10 weeks after chancre appearance; diffuse maculopapular rash teeming with spirochetes; highly infectious
  5. Latency: 3-12 weeks to years; asymptomatic but spirochetes persist in tissues
  6. Tertiary syphilis: 2-20+ years later; involves cardiovascular system (aortitis, aortic aneurysm) and central nervous system (neurosyphilis, dementia), with usually sterile lesions

Immune Evasion Mechanisms

T. pallidum employs sophisticated immune evasion strategies that allow chronic infection lasting decades:
  • Low antigenic mass: Each tissue contains extremely few organisms, possibly below the "critical antigenic mass" required for effective immune recognition
  • Minimal surface antigens: Expresses only about 1% the antigenic targets of E. coli on its outer membrane
  • Antigenic variation: Outer membrane proteins (OMPs) undergo rapid mutation during infection, generating antigenically distinct subpopulations that evade antibody responses
  • Slow multiplication: The extremely slow growth rate (>30 hour generation time) may allow the organism to remain undetected
  • Imperfect immunity: Clinical observations show immunity develops slowly, appearing only in early latency; even then, immunity is incomplete, with approximately one-third of infected individuals eventually clearing infection while others progress to tertiary disease

Transmission and Epidemiology

  • Primary transmission: Direct sexual contact with active primary or secondary lesions (>50% transmission rate with infected partners)
  • Other routes: Nongenital contact (e.g., lip lesions), sharing of contaminated needles, transplacental transmission to fetus
  • Infectivity: Only primary and secondary stages are infectious; tertiary syphilis is noninfectious
  • Host: Exclusively human pathogen under natural conditions
  • Global burden: Approximately 12 million persons infected annually worldwide; 2 million are pregnant women

Diagnostic Methods

Direct visualization:
  • Darkfield microscopy: Most specific for fresh lesion exudates; shows characteristic corkscrew motility
  • Fluorescent antibody testing: Direct or indirect methods for confirmation
Serologic testing (Robbins & Kumar Basic Pathology):
  • Nontreponemal tests (VDRL, RPR): Usually positive early but may be negative in advanced disease; can yield false positives
  • Treponemal tests (FTA-ABS): Become positive later in primary syphilis and remain positive indefinitely; more specific

Pathology

  • Primary and secondary lesions: Demonstrate proliferative endarteritis (inflammation of small blood vessel linings) and plasma cell-rich inflammatory infiltrate
  • Tertiary lesions (gummata): Central area of necrosis surrounded by lymphoplasmacytic infiltrates, activated macrophages, and fibrosis; usually bacteria-free despite severe tissue destruction

Treatment

Penicillin remains the treatment of choice (benzathine penicillin G is the standard formulation):
  • Early syphilis: 2.4 million units intramuscularly as single dose
  • Late latent or unknown duration: 2.4 million units weekly for 3 weeks
  • Penicillin concentration of 0.003 U/mL shows definite treponemicidal activity

Evolution of untreated syphilis:
Disease progression chart showing timeline from inoculation through primary, secondary, latent to tertiary stages with outcomes
Figure: Evolution of untreated syphilis. Following secondary stage resolution, up to 25% of patients relapse within the first 1-2 years. After latency (2-20 years), approximately one-third of untreated individuals develop tertiary complications while others achieve cure; many remain asymptomatic chronically.
This is a shared conversation. Sign in to Orris to start your own chat.